Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald W Busuttil

Showing results (41-50 of 418) with videos related to

Pageof 42
Sort By:
Clinical Transplants|June 24, 2011
Improving outcomes after intestinal transplantation at the University of California, Los AngelesDouglas G Farmer, Robert S Venick, Ronald W Busuttil
The American Surgeon|December 1, 2011
Improvement in short-term pancreas transplant outcome by targeted antimicrobial therapy and refined donor selectionGabriel T Schnickel, Ronald W Busuttil, Gerald S Lipshutz
Clinical Transplants|July 22, 2008
A quarter century of liver transplantation at UCLAJohn P Duffy, Douglas G Farmer, Ronald W Busuttil
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 12, 2015
Adjuvant chemotherapy after liver transplantation for hepatocellular carcinomaAdam S Bodzin, Richard S Finn, Ronald W Busuttil
Journal of Hepatology|August 23, 2005
Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, neverJonathan R Hiatt, Ian C Carmody, Ronald W Busuttil
Hernia : the Journal of Hernias and Abdominal Wall Surgery|September 16, 2006
Collagenase and surgical diseaseTimothy R Donahue, Jonathan R Hiatt, Ronald W Busuttil
JAMA|November 10, 2020
Outpatient Management of Liver Function Test Abnormalities in Patients With a Liver TransplantDanielle S Graham, Ronald W Busuttil, Fady M Kaldas
Annals of Surgery|October 25, 2017
Response: "Which is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?"Vatche G Agopian, William C Chapman, Ronald W Busuttil, et al.
Cancer Journal (Sudbury, Mass.)|April 9, 2008
Surgical resection of hepatocellular carcinomaJohn P Duffy, Jonathan R Hiatt, Ronald W Busuttil
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 15, 2010
Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacySammy Saab, Michael McTigue, Richard S Finn, et al.
Pageof 42

Showing results (41-50 of 418) with videos related to

Sort By:
Pageof 42
Clinical Transplants|June 24, 2011
Improving outcomes after intestinal transplantation at the University of California, Los AngelesDouglas G Farmer, Robert S Venick, Ronald W Busuttil
The American Surgeon|December 1, 2011
Improvement in short-term pancreas transplant outcome by targeted antimicrobial therapy and refined donor selectionGabriel T Schnickel, Ronald W Busuttil, Gerald S Lipshutz
Clinical Transplants|July 22, 2008
A quarter century of liver transplantation at UCLAJohn P Duffy, Douglas G Farmer, Ronald W Busuttil
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 12, 2015
Adjuvant chemotherapy after liver transplantation for hepatocellular carcinomaAdam S Bodzin, Richard S Finn, Ronald W Busuttil
Journal of Hepatology|August 23, 2005
Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, neverJonathan R Hiatt, Ian C Carmody, Ronald W Busuttil
Hernia : the Journal of Hernias and Abdominal Wall Surgery|September 16, 2006
Collagenase and surgical diseaseTimothy R Donahue, Jonathan R Hiatt, Ronald W Busuttil
JAMA|November 10, 2020
Outpatient Management of Liver Function Test Abnormalities in Patients With a Liver TransplantDanielle S Graham, Ronald W Busuttil, Fady M Kaldas
Annals of Surgery|October 25, 2017
Response: "Which is the True Role of Bridging Therapies for HCC Patients Waiting for Liver Transplantation?"Vatche G Agopian, William C Chapman, Ronald W Busuttil, et al.
Cancer Journal (Sudbury, Mass.)|April 9, 2008
Surgical resection of hepatocellular carcinomaJohn P Duffy, Jonathan R Hiatt, Ronald W Busuttil
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|December 15, 2010
Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacySammy Saab, Michael McTigue, Richard S Finn, et al.
Pageof 42